Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 09, 2006. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction and does not contain financial performance data.
Material Changes
The only material change disclosed is a transaction on January 05, 2006, where Mr. J S Heslop purchased Ordinary Shares under a Single Company ISA at a price of GBP14.98 per share. The filing does not provide comparative data against prior periods for this transaction.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It strictly reports a regulatory disclosure of a director's share purchase in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: January 05, 2006
- Individual Involved: Mr. J S Heslop
- Share Price: GBP14.98 per Ordinary Share
- Transaction Type: Purchase under a Single Company ISA
- Notification Date: January 06, 2006 (advised to Company and individual)
- Filing Date: January 09, 2006